Broader treatment coverage is part of the next editorial build.
Condition hub · psoriasis
Psoriasis: understand where phototherapy fits.
This hub is narrow on purpose: it covers the phototherapy decision and hands broader psoriasis treatment depth to specialist resources.
The most useful thing here
Walk in with the right questions.
Save the ones that fit. They remain in this browser until you clear them.
- Given the options available to me, why are we considering phototherapy now?Saving keeps this on your device and needs JavaScript, which is off in this browser.
- Are any symptoms I mentioned better handled in a separate conversation or referral?Saving keeps this on your device and needs JavaScript, which is off in this browser.
- What would make us pause, change, or reconsider this plan?Saving keeps this on your device and needs JavaScript, which is off in this browser.
Find the right depth
The treatment landscape.
No ranked ladder and no implied completeness. Each row says where the depth lives.
If phototherapy is on the table
The decision is only the beginning.
SteadySkin is building the practical path around the clinical conversation.
Sources
British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022
British Journal of Dermatology (Goulden V, et al.)
Regulatory / guidelineIndependent
- Published
- 2022-09-01
- Last checked by us
- 2026-07-29
Read the sourceWhat this source does and does not support
Supports that therapeutic narrowband UVB lamps have an emission spectrum peaking near 311–313 nm, and that this narrow band was selected because it is the most effective part of the UVB spectrum for treating psoriasis. It is a clinical guideline for clinicians administering phototherapy; it does not establish any home-use dose, and this site never reproduces its dosing schedules.
Phototherapy — NB-UVB (patient information leaflet)
British Association of Dermatologists
Patient educationIndependent
- Published
- 2022-06-01
- Last checked by us
- 2026-07-29
Read the sourceWhat this source does and does not support
Supports, in plain patient-facing language, that narrowband UVB uses a small part of the UVB spectrum and is used for skin conditions including psoriasis, eczema and vitiligo. As patient-education material it is context, not primary evidence, for any efficacy claim. Its review date is June 2025, so re-verify before relying on it past then.
About the SteadySkin app
The app currently supports vitiligo only.
Psoriasis support is planned, without a promised date. This website remains usable without the app, and this page does not send you to a vitiligo-only download.